Vincent Wong
Director/Board Member at BIONANO GENOMICS, INC.
Net worth: - $ as of 2024-06-29
Profile
Vincent J.
Wong is an Independent Director at Bionano Genomics, Inc. He previously served as the Chief Commercial Officer at Geneoscopy, Inc. from 2021 to 2024.
Mr. Wong has an undergraduate degree from the University of Notre Dame, an MBA from Kellogg School of Management, and a graduate degree from Indiana University Maurer School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
-.--% | 2024-06-17 | 0 ( -.--% ) | - $ | 2024-06-29 |
Vincent Wong active positions
| Companies | Position | Start |
|---|---|---|
| BIONANO GENOMICS, INC. | Director/Board Member | 2021-12-21 |
Former positions of Vincent Wong
| Companies | Position | End |
|---|---|---|
Geneoscopy, Inc.
 Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Corporate Officer/Principal | 2023-12-31 |
Training of Vincent Wong
| University of Notre Dame | Undergraduate Degree |
| Indiana University Maurer School of Law | Graduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Geneoscopy, Inc.
Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Commercial Services |
- Stock Market
- Insiders
- Vincent Wong
